FADD and cancer: Functional enrichment suggests that the high FADD phenotype is enriched in purine pyrimidine metabolism-related pathways and cell cycle-related pathways, which are hallmarks and one of the fundamental mechanisms of cancer, suggesting that high FADD is a dysregulated, hyperproliferative LUAD subtype (25, 26).